BIOGEN INC. (BIIB) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $27.6 billion, BIOGEN INC. is a large-cap company. The stock currently trades at $188.05, down 1.97% today, with a 52-week range of $110.04–$202.41. The company trades at a trailing P/E of 21.4x and a forward P/E of 11.6x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $8.79 | $8.83 | -21.4% | |
| 2024 | $11.18 | $11.21 | +40.3% | |
| 2023 | $7.97 | $8.02 | -61.8% | |
| 2022 | $20.87 | $20.96 | +100.7% | |
| 2021 | $10.40 | $10.44 | +348.3% | |
| 2020 | $2.32 | $2.33 | -71.3% | |
| 2019 | $8.08 | $8.10 | +70.8% | |
| 2018 | $4.73 | $4.74 | +437.9% | |
| 2017 | $-1.40 | $-1.41 | -146.8% | |
| 2016 | $2.99 | $3.00 | -20.7% | |
| 2015 | $3.77 | $3.77 | +0.8% | |
| 2014 | $3.74 | $3.75 | +94.8% | |
| 2013 | $1.92 | $1.94 | +56.1% | |
| 2012 | $1.23 | $1.24 | +0.8% | |
| 2011 | $1.22 | $1.24 | +23.2% | |
| 2010 | $0.99 | $1.00 | -70.4% | |
| 2009 | $3.35 | $3.37 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-06 | 0000875045-26-000013 | SEC ↗ |
| 2024-12-31 | 2025-02-12 | 0000875045-25-000009 | SEC ↗ |
| 2023-12-31 | 2024-02-14 | 0000875045-24-000009 | SEC ↗ |
| 2022-12-31 | 2023-02-15 | 0000875045-23-000009 | SEC ↗ |
| 2021-12-31 | 2022-02-03 | 0000875045-22-000007 | SEC ↗ |
| 2020-12-31 | 2021-02-03 | 0000875045-21-000010 | SEC ↗ |
| 2019-12-31 | 2020-02-06 | 0000875045-20-000005 | SEC ↗ |
| 2018-12-31 | 2019-02-06 | 0000875045-19-000006 | SEC ↗ |
| 2017-12-31 | 2018-02-01 | 0000875045-18-000005 | SEC ↗ |
| 2016-12-31 | 2017-02-02 | 0000875045-17-000009 | SEC ↗ |
| 2015-12-31 | 2016-02-03 | 0000875045-16-000042 | SEC ↗ |
| 2014-12-31 | 2015-02-04 | 0000875045-15-000005 | SEC ↗ |